Status:

RECRUITING

Biology of Young Lung Cancer Study: The YOUNG LUNG Study

Lead Sponsor:

Dana-Farber Cancer Institute

Conditions:

Non Small Cell Lung Cancer

Small Cell Lung Carcinoma

Eligibility:

All Genders

15+ years

Brief Summary

The purpose of this research study is to learn more about lung cancer (NSCLC or SCLC) diagnosed in adults at ages 45 or younger.

Detailed Description

This research study looks to enroll as many people diagnosed with lung cancer at 45 years old or younger in order to: * Better understand causes of lung cancer in individuals 45 years old and younger...

Eligibility Criteria

Inclusion

  • Age 45 and under at lung cancer diagnosis
  • Pathologically confirmed bronchogenic lung carcinoma (NSCLC or SCLC of any stage) at any treatment time point
  • Provision of written informed consent
  • Willingness to undergo no more than two (2) peripheral blood draws in a four (4) week period, with no more than 50 ml peripheral blood collected over eight (8) weeks
  • Individuals under age 18 are eligible for study if they meet defined criteria; in addition, consent for participation must be given by a legal guardian or parent

Exclusion

  • Individuals who decline to sign consent
  • Individuals who are unable to give consent or assent and are without a designated healthcare proxy
  • Compromise of patient diagnosis or staging if tissue is used for research

Key Trial Info

Start Date :

January 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 1 2027

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT05265429

Start Date

January 1 2023

End Date

August 1 2027

Last Update

October 29 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

2

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02115

3

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

4

Dana-Farber Cancer Institute

Boston, Massachusetts, United States, 02115